T-Maze Spontaneous Alternation

Overview

The T-maze spontaneous alternation task exploits the innate tendency of rodents to explore novel environments by measuring their propensity to alternate arm choices across successive trials. Spatial working memory is assessed by the animal's ability to remember which arm was previously visited and choose the opposite arm on the subsequent trial. This paradigm is sensitive to hippocampal lesions, pharmacological manipulations targeting cholinergic and glutamatergic systems, and transgenic models of Alzheimer's disease.

Primary dependent variables include the percentage of spontaneous alternation (ratio of alternating choices to total possible alternations), arm entry latency, total number of arm entries, and time spent in each arm. Additional measures such as return latency (time between consecutive arm entries) and perseverative errors (repeated entries into the same arm) provide further insight into spatial working memory integrity and behavioral flexibility.

ConductMaze automates T-maze alternation testing with infrared beam-break arrays at arm entrances and choice points, enabling real-time detection of arm entries without manual observation. The system controls guillotine door actuators to manage forced-choice and free-choice phases, logs all spatial coordinates and timestamps, and computes alternation scores, latencies, and error types automatically. Session parameters including inter-trial interval, number of trials, and door timing are fully programmable.

Trial Flow

start

Place Animal

Subject is placed in the start arm of the T-maze facing the choice point.

process

Forced Run

One arm is blocked via guillotine door; animal enters the open arm (sample phase).

process

Confinement

Animal is confined in the chosen arm for the specified sample duration.

process

Return to Start

Animal is returned to start arm; both guillotine doors are opened simultaneously.

decision

Free Choice

Animal chooses between left and right arms; entry is logged when all four paws cross the arm threshold.

output

Score Alternation

Choice is compared to previous trial; alternation or perseveration is recorded with latency.

process

Inter-Trial Interval

Animal is held in a waiting area for the configured ITI before the next trial begins.

end

Session Complete

After all trials are completed, summary statistics are computed and exported.

Parameters

ParameterTypeDefaultDescription
Number of Trialsinteger14Total number of free-choice trials per session.
Inter-Trial Intervalduration30sTime between the end of one trial and the start of the next.
Sample Durationduration30sConfinement time in the forced-choice arm during the sample phase.
Choice Timeoutduration120sMaximum time allowed for the animal to make an arm choice.
Arm Entry Thresholddistance5cmDistance past the choice point that constitutes a committed arm entry.
Forced Arm SequenceenumpseudorandomPattern of forced-choice arm assignments: alternating, random, or pseudorandom.
Door Close Delayduration2sTime after arm entry before the guillotine door closes behind the animal.

Metrics

MetricUnitDescription
Alternation Rate%Percentage of trials where the animal chose the arm not visited on the previous trial.
Arm Entry LatencysTime from door opening to the animal crossing the arm entry threshold.
Perseverative ErrorscountNumber of consecutive entries into the same arm across trials.
Total Arm EntriescountTotal number of arm entries across all trials in the session.
Time in Chosen ArmsDuration spent in the selected arm per trial before return.
Choice Point HesitationsTime spent in the choice point zone before committing to an arm.

Sample Data

TrialForced ArmChosen ArmAlternationLatency (s)Hesitation (s)

Representative data for illustration purposes. Actual values will vary by species, strain, and experimental conditions.

Applications

  • 1
    Hippocampal FunctionAssessing spatial working memory deficits following dorsal hippocampal lesions or optogenetic silencing of CA1 pyramidal neurons.
  • 2
    Alzheimer's Disease ModelsLongitudinal tracking of cognitive decline in APP/PS1, 3xTg-AD, and 5xFAD transgenic mouse lines across age.
  • 3
    Cholinergic PharmacologyEvaluating procognitive effects of acetylcholinesterase inhibitors (donepezil, galantamine) and muscarinic receptor agonists.
  • 4
    Neurodevelopmental DisordersCharacterizing spatial memory phenotypes in models of Down syndrome, Fragile X, and autism spectrum disorders.
  • 5
    Acute Drug ScreeningRapid assessment of cognitive side effects for anxiolytics, antipsychotics, and novel compounds in preclinical pipelines.

Compatible Products

ME-TMAZECS-958344

Ready to Automate Your Behavioral Protocols?

Contact us for a demo and pricing information.